Usage of Long Acting Reversible Contraceptive Methods among Women Who Want No More Children, In-Depth Analysis of the Ethiopian Demographic and Health Survey 2005
Science Journal of Public Health
Volume 5, Issue 6, November 2017, Pages: 428-439
Received: Sep. 20, 2017;
Accepted: Sep. 28, 2017;
Published: Nov. 6, 2017
Views 979 Downloads 30
Seyfu Abebe Desta, School of Public Health, University of Gondar, Gondar, Ethiopia
Alemayehu Worku, School of Public Health, University of Gondar, Gondar, Ethiopia
Problem Statement: The Long Acting Reversible Contraceptive Methods were known to provide different benefits for the client and the health system when compared with the short acting methods. Despite these advantages, these methods are underutilized in the world in general and in Ethiopia in particular with a prevalence rate of 0.2%. Detrmining the factors for usage of Long Acting Reversible Contraceptives among women who want no more children not only help to plan interventions and increase their utilization of these methods but also will have significant contribution to improve the health system provision due to the diversified benefit. The objective of this study was to figure out the main factor that determines the use of long acting reversible contraceptive methods among current users who want no more children in 2005 in Ethiopia. The in-depth analysis of this study was based on the Ethiopian Demography and Health survey conducted on 2005 G. C. Data pertaining to this study was taken from the survey and analyzed using SPSS 19. Multiple binary logistics regressions were used to find relationship between the independent and dependent variable using Complex survey analysis. After adjusting for demographic and reproductive health characteristics, highest education attained, ever had a terminated pregnancy, heard Family planning on radio, told about FP by health or FP worker and decision maker on use of contraception were found to be determinants for the use of Long Acting Reversible Contraceptives. The study has identified highest level of education attained, ever had a terminated pregnancy, heard FP on radio and decision maker on using contraception were found to be determinates. Approaches that address the mentioned factors will significantly enhance the use of the Long Acting Reversible Contraceptives in this subpopulation.
Seyfu Abebe Desta,
Usage of Long Acting Reversible Contraceptive Methods among Women Who Want No More Children, In-Depth Analysis of the Ethiopian Demographic and Health Survey 2005, Science Journal of Public Health.
Vol. 5, No. 6,
2017, pp. 428-439.
Hubacher D, Mavranezouli I, McGinn E. Unintended Pregnancy in Sub-Saharan Africa: Magnitude of the Problem and Potential Role of Contraceptive Implants. Contraception 2008; 78:73-78.
United nations, Department of Economic and Social Affairs, Population Division (2011). World Contraceptive Use 2010(POP/DB/ Rev 2010).
Ethiopia Central Statistical Authority. Ethiopian Demographic Health Survey 2000.
Ethiopia Central Statistical Authority. Ethiopian Demographic Health Survey 2005.
Osei I, Birungi H, Addico G, Askew I, Gyapong JO. What Happened to the IUD in Ghana? African Journal of Reprod Health 2005:9(2):76-95.
McDonald-Mosley R., Philips K., Ditzian L., Cremer M. Acceptability of the Intrauterine Device among Women in El Salvador. International Journal of Gynecology And Obstetrics 2010; 108:152-160.
Katz KR., Johnson LM., Janowitz B, Carranza JM. Reason for the Low Level of IUD Use in El Salvador. International Family planning Perspective 2002; 28(1):26-31.
Thang NM, Huong VT. Changes In Contraceptive Use in Vietnam. J Biosoc sci. 2003; 35:527-543.
Magadi MA, Curtis SL. Trends and Determinant of Contraceptive Method Choice in Kenya. Studies in family planning 2003; 34(3):149-159.
Seiber EE, Bertrand JT, Sullivan TM. Changes in Contraceptive Method Mix In Developing Countries. International Family Planning Perspective 2007; 33(3):117-123.
Brown W, Ottney A, Nguyen S. Breaking the Barrier: The Health Belief Model and Patient Perceptions Regarding Contraception. Contraception 2011:83(5):453-458.
Steiner MJ., Trussell J., Mehta N., Condon S., Subramaniam S., Bourne D. Communicating contraceptive effectiveness: A randomized controlled trial to inform a World Health Organization family planning handbook. American Journal of Obstetrics and Gynecology 2006; 195: 85–91.
Trussell J. Contraceptive failure in the United States. Contraception 2004; 70:89-96.
Meirik O, Farley TM, Sivin I. Safety and efficacy of Levnogestril Implants, Intrauterine Device, and sterilization. Obst Gynecol 2001; 97:539-471.
Clare Lipetz C., Phillips CJ., Fleming CF. The cost-effectiveness of a long-acting reversible contraceptive (Implanon®) relative to oral contraception in a community setting. Contraception 2009; 79:304-309.
Mavranezouli I, Wilkinson C. Long-acting reversible contraceptives: not only effective, but also a cost-effective option for the National Health Service. J Fam Plann Reprod Health Care. 2006; 32(1):3-5.
Frost JJ, Darroch JE. Factors Associated with contraceptive choice and inconsistent method use, United States. 2004. Perspectives on Sexual and Reproductive Health, 2008, 40(2):94–104, doi: 10.1363/4009408.
Kane R, Irving G, Brown S, Parkes N, Walling M, Killick S. Long acting, reversible and permanent method of contraception; Insight in to women’s` choice of method. Quality in primary care 2009; 17:107-114.
Mitchel MJ, Thistle P. Acceptability of levonorgestrel subdermal implants versus tubal ligation for long-term contraception in a rural population of Zimbabwe Contraception 2004; 70(6):483-486.
Baveja R, Buckshee K, Das K, Das SK, Hazra MN, Gopalan S. Evaluating contraceptive method choice using the method mix approach. Contraception 2000; 61:113-119.
Renee C., Wong RC., Bell RJ, Thunuguntla K., McNamee K., Vollenhovena B. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users Contraception 2009; 80:452-456.
Kavanaugh ML, Jerman J, Hubacher D, Kost K, Lawrence B. Finer LB. Characteristics of women in the US who use Long acting reversible methods. Obstet Gyncol 2011; 117:1349-57
Neukoma J, Chilambweb J, Mkandawireb J, Mbewec RK, Hubacherd D. Dedicated providers for long acting reversible contraception: new approach in Zambia. Contraception 2011; 83:447-452.
Gutin SA., Mlobeli R, Moss M, Buga G, Morroni C. Survey of knowledge, attitude and practice surrounding the intrauterine device in South Africa. Contraception 2011; 83:145-150.
Ali M, Cleland J. Determinant Of Contraceptive Discontinuation In Six Developing Countries. J. Biosoc, sci 1999; 31:343-360.
Gilliam ML, Warden M., Goldstein C., Tapia B. Concerns about contraceptive side effects among young Latinas; a focus group approach. Contraception 2004; 70:299-305.
Fertility and family planning in Ethiopia, A new look at data from the 2005 Ethiopia Demographic and Health survey.
Ruminjo JK., Amatya RN., Dunson TR., Krueger SL., Chi I. Norplant implants, Acceptability and User Satisfaction Among Women in Two African Countries. Contraception 1996; 53:101-107.
Rivera R., Chen-Mok M., McMullen S. Analysis of client characteristics that may affect early discontinuation of copper IUD. Contraception 1999; 60:155-60.
Hubacher D., Goco N., Gonzalez B, Doug Taylor D. Factors affecting continuation rate of DMPA. Contraception 2000; 60:345-351.
Summary and Statistical Report of the 2007 Population and Housing Census. Federal Democratic Republic of Ethiopia Population census commission; December 2008.
Hubacher D, Kimani J, Steiner MJ, Solomon M, Ndugga MB. Contraceptive Implants in Kenya; current practice and future prospects. Contraception 2007; 75:468-473.
Alemayehu M. Belachew T., Tizta T. Factors associated with the utilization of long and permanent contraceptive methods among married women of reproductive age in Mekelle town, Tigray region, north Ethiopia. BMC Pregnancy and Childbirth 2012 12:6.